Winding Down River Road

As a mechanism to explore my temporary home in Louisiana, Winding Down River Road is a collection of artworks that integrates natural materials collected from landscapes in southern Louisiana with steel and petroleum-based products. My interest in researching environmental issues, ecology, and industry has shaped my vehicles for observation and how I generate data. Through a variety of methodologies, I am considering how climate change is forcing many of us to re-contextualize how our home can be affected by the very industries we rely on. Personal engagement with residents living in the dystopian atmosphere of southern Louisiana’s industrial corridor and the rapidly disappearing coastal communities shaped my understanding of rooted connection to place. What began as a class field trip along an infamous byway between Baton Rouge and New Orleans sparked a multi-year study of this unique environment impacted by industrial infrastructure and systems that ultimately disrupt the landscape

Using administrative data to estimate the population and applications

Research findings report of USING ADMINISTRATIVE DATA TO ESTIMATE THE POPULATION AND APPLICATIONS project. A project in the ESRC Understanding Population Trends and Processes Programme, maintained by the ReStore repository and archived to NCRM Eprints 2022

Expert nurse to novice academic: Reflections on the first year of transition from practitioner to academic

Harper-McDonald, B., & Taylor, G. (2020). Expert nurse to novice academic: Reflections on the first year of transition from practitioner to academic. Nurse Education Today, 90, https://doi.org/10.1016/j.nedt.2020.10443

Celebrating 70 years of nursing and midwifery in NHS Scotland. [Exhibition]

This set of infographics were displayed together in an exhibition celebrating 70 years of nursing and midwifery in NHS Scotland. They highlight events and images covering each decade of the history of NHS Scotland, from the 1940s through to present day and beyond

Celebrating 70 years of Nursing and Midwifery in our National Health Service (NHS) Scotland

No abstract available

Celebrating 70 years of Nursing and Midwifery in our National Health Service (NHS) Scotland

No abstract available

Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer's disease: the MADE Phase II, three-arm RCT

Background: Minocycline is an anti-inflammatory drug and protects against the toxic effects of β-amyloid in vitro and in animal models of Alzheimer’s disease. To the best of our knowledge, no randomised placebo-controlled clinical trials in patients with Alzheimer’s disease looking at the efficacy and tolerability of minocycline have been carried out. Objectives: The trial investigated whether or not minocycline was superior to placebo in slowing down the rate of decline in cognitive and functional ability over 2 years. The safety and tolerability of minocycline were also assessed. Design: A Phase II, three-arm, randomised, double-blind, multicentre trial with a semifactorial design. Participants continued on trial treatment for up to 24 months. Setting: Patients were identified from memory services, both within the 32 participating NHS trusts and within the network of memory services supported by the Dementias and Neurodegenerative Diseases Research Network (also known as DeNDRoN). Participants: Patients with standardised Mini Mental State Examination scores of > 23 points and with Alzheimer’s disease assessed by the National Institute on Aging–Alzheimer’s Association’s criteria were identified from memory services. Intervention: Patients with mild Alzheimer’s disease were randomly allocated 1 : 1 : 1 to receive one of three treatments: arm 1 – 400 mg per day of minocycline; arm 2 – 200 mg per day of minocycline; or arm 3 – placebo. Patients continued treatment for 24 months. Participants, investigators and outcome assessors were blind to treatment allocation. Main outcome measures: Primary outcome measures were decline in standardised Mini Mental State Examination and Bristol Activities of Daily Living Scale scores of combined minocycline treatment arms versus placebo, as analysed by intention-to-treat repeated measures regression. Results: Between 23 May 2014 and 14 April 2016, 554 participants were randomised. Of the 544 eligible participants, the mean age was 74.3 years and the average standardised Mini Mental State Examination score was 26.4 points. A total of 252 serious adverse events were reported, with the most common categories being neuropsychiatric and cardiocirculatory. Significantly fewer participants completed treatment with 400 mg of minocycline [29% (53/184)] than 200 mg [62% (112/181)] or placebo [64% (114/179)] (p < 0.0001), mainly because of gastrointestinal symptoms (p = 0.0008), dermatological side effects (p = 0.02) and dizziness (p = 0.01). Assessment rates were also lower in the 400-mg treatment arm: 68% (119 of 174 expected) for standardised Mini Mental State Examination scores at 24 months, compared with 82% (144/176) for the 200-mg treatment arm and 84% (140/167) for the placebo arm. Decline in standardised Mini Mental State Examination scores over the 24-month study period in the combined minocycline arms was similar to that in the placebo arm (4.1- vs. 4.3-point reduction; p = 0.9), as was the decline in the 400- and 200-mg treatment arms (3.3 vs. 4.7 points; p = 0.08). Likewise, worsening of Bristol Activities of Daily Living Scale scores over 24 months was similar in all trial arms (5.7, 6.6 and 6.2 points in the 400-mg treatment arm, 200-mg treatment arm and placebo arm, respectively; a p-value of 0.57 for minocycline vs. placebo and a p-value of 0.77 for 400 vs. 200 mg of minocycline). Results were similar in different patient subgroups and in sensitivity analyses adjusting for missing data. Limitations: Potential limitations of the study include that biomarkers were not used to confirm the diagnosis of Alzheimer’s disease, as these and apolipoprotein E (APOE) genotyping are not routinely available within the NHS. Compliance was also worse than expected and differential follow-up rates were observed, with fewer assessments obtained for the 400-mg treatment arm than for the 200-mg treatment and placebo arms. Conclusions: Minocycline does not delay the progress of cognitive or functional impairment in people with mild Alzheimer’s disease over a 2-year period. Minocycline at a dose of 400 mg is poorly tolerated in this population. Future work: The Minocycline in mild Alzheimer’s DiseasE (MADE) study provides a framework for a streamlined trial design that can be usefully applied to test other disease-modifying therapies

Using Administrative Data to Count and Classify Households with Local Applications

Households rather than individuals are being increasingly used for research and to target and evaluate public policy. As a result accurate and timely household level statistics have become an increasing necessity especially at local level. However, official sources of information on households are fragmented with significant gaps and inaccuracies that limit their usefulness. This paper reviews present statistical arrangements and then describes a new approach to data collection and household classification which combine various local administrative sources. An intermediate step is the creation of local population counts which are converted into household types and these methods are described in two companion papers previously published in this journal. The utility and advantages of the approach are demonstrated using the example of the six Olympic London Boroughs for whom the data collection was undertaken in 2011 and the analysis subsequently

Using Administrative Data to Count Local Populations

There is growing evidence that official population statistics based on the decennial census are inaccurate at the local authority level—the fundamental administrative unit of the UK. This paper investigates the use of locally available administrative data sets for counting populations. The method uses truth tables for combining different data sources with different population coverage according to a defined and therefore replicable set of rules. The result is timelier and geographically more flexible data which is more cost-effective to produce than a survey-based census. Associated techniques for linking diverse data sources at individual and household level are briefly discussed. The methodology is then applied to administrative data from a London borough with about 170,000 people. The results are evaluated and compared with other population sources. The paper concludes by discussing potential improvements including scaling up the work to cover multiple local authorities. The practicalities of using alternative central government data sets are briefly considered. A sequel paper in this journal provides examples of key applications of this approach at local level

Applications of Population Counts Based on Administrative Data at Local Level

The House of Commons Treasury Committee (2008) identified the three main purposes of population statistics as resource allocation, population ratios and local planning and intelligence, and described current population estimates as ‘unfit for purpose’. This paper considers the limitations of current population statistics in the context of these purposes and how using administrative data available at local authority level can overcome them. A sequel to a companion paper in this journal dealing with the population counting methodology, it considers how administrative data can be captured and organised at a local level for the benefit of local service providers and communities. A detailed example based on one London local authority shows the results of this approach in applications related to the three purposes given. A concluding section reflects on the wider applicability of the approach